necessary to ensure that the patient will have access tosuitable analgesia.Pa<strong>in</strong> after surgery is usually most severe <strong>in</strong> the first24–72 h but may persist for several days or weeks.Analgesia can be given regularly (by the clock) <strong>in</strong> theearly postoperative period <strong>and</strong> then ‘as required’accord<strong>in</strong>g to assessed pa<strong>in</strong>. Drugs to counteractunwanted effects of analgesia or other side effects ofsurgery such as PONV should also be available <strong>and</strong>adm<strong>in</strong>istered when necessary.<strong>Postoperative</strong> pa<strong>in</strong> should be assessed frequently: seesection 3.0 for further <strong>in</strong>formation. Analgesic regimensshould be sufficiently flexible to allow for <strong>in</strong>ter-<strong>in</strong>dividualdifferences <strong>in</strong> the response to analgesics <strong>and</strong> thevariation <strong>in</strong> the requirement for pa<strong>in</strong> relief that occursdur<strong>in</strong>g the postoperative period.5.2 ENT surgery5.2.1 Myr<strong>in</strong>gotomyDra<strong>in</strong>age of the middle ear, usually with <strong>in</strong>sertion of atube, is a treatment for otitis media. Myr<strong>in</strong>gotomy isusually considered to be a m<strong>in</strong>or procedure, undertakenon a day-case basis. See also section 5.1 for thegeneral pr<strong>in</strong>ciples of postoperative pa<strong>in</strong> management.<strong>Good</strong> practice po<strong>in</strong>tAs myr<strong>in</strong>gotomy is a brief procedure, oral paracetamolor NSAID should be adm<strong>in</strong>istered preoperativelyto ensure adequate analgesia at the end of surgery.RecommendationsOral paracetamol or NSAIDS (ibuprofen, diclofenac, orketorolac) <strong>in</strong> suitable doses can achieve adequate earlypostoperative analgesia: Grade B (1–4).Opioids are effective but not recommended for rout<strong>in</strong>euse because of side effects: Grade B (1,5–8).EvidenceParacetamol (oral) produces dose-related analgesia;10 mgÆkg )1 is no better than placebo (3) or is associatedwith higher supplemental requirements (8), whereas pa<strong>in</strong>scores are lower with 15–20 mgÆkg )1 (1,2,4,5,9).Ibuprofen <strong>and</strong> diclofenac appear to provide similaranalgesia to paracetamol (2,10), but the comb<strong>in</strong>ationhas not been tested.Ketorolac 1 mgÆkg )1 (<strong>in</strong>travenous) provides m<strong>in</strong>orimprovements <strong>in</strong> analgesia when compared with lowdoses of paracetamol, 10 mgÆkg )1 (3,8); paracetamol10 mgÆkg )1 + code<strong>in</strong>e 1 mgÆkg )1 (8); paracetamol15 mgÆkg )1 (but only first 10 m<strong>in</strong> there was no differenceat 20 m<strong>in</strong>) (4). See section 6.5 for recommendeddoses of ketorolac <strong>and</strong> other NSAIDS.Opioids, for example code<strong>in</strong>e, butorphanol, orfentanyl, have been associated with <strong>in</strong>creased sideeffects when compared with NSAIDs or paracetamol,without cl<strong>in</strong>ically significant improvements <strong>in</strong> analgesia;therefore, their use is not warranted for rout<strong>in</strong>emyr<strong>in</strong>gotomy:i. <strong>in</strong>creased sedation <strong>and</strong> time to discharge for oralcode<strong>in</strong>e: (1), nasal fentanyl (7) <strong>and</strong> nasal butorphanol (6)ii. <strong>in</strong>creased vomit<strong>in</strong>g with oral code<strong>in</strong>e or nasal butorphanol(8).LA block of the auricular branch of the vagus providedequivalent analgesia to <strong>in</strong>tranasal fentanyl (11).Analgesia Table 5.2.1Opioid a 1)NSAID 1)Paracetamol 1)Directevidencea Not rout<strong>in</strong>ely recommended because of side effects: see text.5.2.2 TonsillectomyTonsillectomy (±adenoidectomy) is one of the mostfrequently performed procedures <strong>in</strong> children. Chronicor recurrent tonsillitis with tonsillar hyperplasia lead<strong>in</strong>gto upper airway obstruction, for example <strong>in</strong> sleepapnea syndromes, is the most frequent <strong>in</strong>dication fortonsillectomy. The choice of analgesia, postoperativemonitor<strong>in</strong>g, <strong>and</strong> duration of hospital admission is<strong>in</strong>fluenced by the potential for serious complicationssuch as apnea, perioperative bleed<strong>in</strong>g, <strong>and</strong> postoperativenausea <strong>and</strong> vomit<strong>in</strong>g (PONV). Pa<strong>in</strong> after tonsillectomycan persist for many days. See also section 5.1for the general management of postoperative pa<strong>in</strong>.<strong>Good</strong> practice po<strong>in</strong>tAs significant levels of pa<strong>in</strong>, behavioral disturbance, sleepdisruption, <strong>and</strong> altered activity can persist for 5–8 daysfollow<strong>in</strong>g tonsillectomy, regular adm<strong>in</strong>istration of analgesiamay be necessary dur<strong>in</strong>g this period. Information forfamilies about pa<strong>in</strong> assessment <strong>and</strong> medication use follow<strong>in</strong>gdischarge is particularly important.34 ª 2012 Blackwell Publish<strong>in</strong>g Ltd, Pediatric Anesthesia, 22 (Suppl. 1), 1–79
RecommendationsA comb<strong>in</strong>ation of <strong>in</strong>dividually titrated <strong>in</strong>traoperative opioids,dexamethasone, <strong>and</strong> regularly adm<strong>in</strong>istered perioperativemild analgesics (NSAIDS <strong>and</strong>/or paracetamol) isrecommended for management of tonsillectomy pa<strong>in</strong>:Grade A (12,13).Topical application or <strong>in</strong>jection of local anesthetic <strong>in</strong> thetonsillar fossa improves early pa<strong>in</strong> scores follow<strong>in</strong>g tonsillectomy:Grade A (14,15).Tramadol can produce similar analgesia to morph<strong>in</strong>e orpethid<strong>in</strong>e: Grade B (16–18).Peritonsillar <strong>in</strong>jection of tramadol has no advantage oversystemic adm<strong>in</strong>istration: Grade B (19,20).Intraoperative <strong>in</strong>travenous ketam<strong>in</strong>e does not providesignificant postoperative advantage compared with opioid:Grade B (16,17,21,22).Implementation of st<strong>and</strong>ardised protocols <strong>in</strong>clud<strong>in</strong>g <strong>in</strong>traoperativeopioid ± anti-emetic, perioperative NSAID(diclofenac or ibuprofen), <strong>and</strong> paracetamol is associatedwith acceptable pa<strong>in</strong> relief <strong>and</strong> low rates of PONV:Grade C (23,24).EvidenceSignificant levels of pa<strong>in</strong>, behavioral disturbance, sleepdisruption, <strong>and</strong> altered activity can persist for 5–8 daysfollow<strong>in</strong>g tonsillectomy (25–28). Regular adm<strong>in</strong>istrationof paracetamol <strong>and</strong> NSAID is necessary for severaldays postoperatively, <strong>and</strong> adequate parentaleducation about pa<strong>in</strong> assessment <strong>and</strong> medication use isrequired.Opioids: Intraoperative opioids are given dur<strong>in</strong>g tonsillectomy<strong>and</strong> may be required <strong>in</strong> the postoperativeperiod (12). Morph<strong>in</strong>e is the prototype opioid, butthere has been some <strong>in</strong>terest <strong>in</strong> the use of tramadol follow<strong>in</strong>gtonsillectomy.Tramadol produces similar analgesia <strong>and</strong> side effectsto morph<strong>in</strong>e (29) <strong>and</strong> pethid<strong>in</strong>e (16). Tramadol1mgÆkg )1 was equianalgesic with IV paracetamol15 mgÆkg )1 <strong>in</strong> one study (30). One study reported lessnausea with tramadol than morph<strong>in</strong>e (18). In patientswith sleep apnea tramadol was associated with fewerepisodes of oxygen desaturation at one time po<strong>in</strong>tpostoperatively (1–2 h, no difference at earlier or latertime po<strong>in</strong>ts to 6 h) (29). Comparison of <strong>in</strong>travenous<strong>and</strong> peritonsillar <strong>in</strong>jection of tramadol 2 mgÆkg )1reported m<strong>in</strong>or improvements with peritonsillar <strong>in</strong>jection(19), but effects are likely to be related to systemicabsorption. Tramadol 1 mgÆkg )1 (IV), 2 mgÆkg )1 (IM),or 3 mgÆkg )1 by peri-tonsillar <strong>in</strong>jection reduced pa<strong>in</strong>scores when compared with placebo (20,31). Of particularconcern, children <strong>in</strong> these placebo groups receivedno <strong>in</strong>tra-operative analgesia. However, tramadol wasless effective than ketoprofen (higher pa<strong>in</strong> scores <strong>and</strong>higher postoperative PCA fentanyl) <strong>and</strong> did not differfrom placebo <strong>in</strong> one study (32).NSAIDS improve analgesia when compared withplacebo (10/11 studies) <strong>and</strong> provide similar analgesiato opioids (7/8 studies) <strong>and</strong> paracetamol (3/3 studies)(33). A systematic review found that heterogeneity ofthe data precluded meta-analysis, <strong>and</strong> many studiescompar<strong>in</strong>g two active treatments were not sensitiveenough to show a difference (12). Subsequent studieshave reported similar analgesia with ketorolac <strong>and</strong>fentanyl (34), no improvement with addition of rofecoxibto opioid <strong>and</strong> paracetamol (35), <strong>and</strong> no difference<strong>in</strong> pa<strong>in</strong> scores but <strong>in</strong>creased rescue analgesicrequirements with IV paracetamol compared withpethid<strong>in</strong>e (36). Ketoprofen improved analgesia <strong>in</strong> thefirst 6 h postoperatively <strong>in</strong> comparison with tramadolor placebo (32).Paracetamol is more effective given orally prior tosurgery than rectally after <strong>in</strong>duction of anesthesia, itreduces opioid requirements <strong>and</strong> PONV (37–39).Local anesthesia: Two recent meta-analyses reportedstatistically significant reductions <strong>in</strong> postoperative pa<strong>in</strong>scores with local anesthetic techniques for up to 48 h,but the effect size decreased after the first 4–6 h(14,15). Topical application <strong>and</strong> <strong>in</strong>filtration wereequally effective (14), <strong>and</strong> no difference was foundbetween LA <strong>in</strong>filtration before or after removal of thetonsils (15). <strong>Postoperative</strong> analgesic requirements werereduced (15), but there was no significant difference <strong>in</strong>adverse events (14) or PONV (15). In additional studies,bupivaca<strong>in</strong>e <strong>in</strong>filtration <strong>and</strong> topical levobupivaca<strong>in</strong>eswabs improved pa<strong>in</strong> scores but did not alterPONV (40,41). Others reported no benefit with peritonsillarLA <strong>in</strong>filtration (42) <strong>and</strong> similar analgesiawhen topical 2% viscous lignocane was compared withrectal diclofenac (43).Ketam<strong>in</strong>e (IV) improves analgesia when comparedwith placebo (21,44,45) but provides no advantagewhen compared with equianalgesic opioid (17,46) <strong>and</strong>may <strong>in</strong>crease side effects (22). Addition of ketam<strong>in</strong>e0.25 mgÆkg )1 to morph<strong>in</strong>e 0.1 mgÆkg )1 did not significantlyimprove analgesia (47). Topical application onswabs (ketam<strong>in</strong>e 20 mg <strong>in</strong> children aged 3–12 years)(48) or peritonsillar <strong>in</strong>filtration reduced very earlypa<strong>in</strong> scores <strong>and</strong> opioid requirements (49), effects mayrelate to systemic absorption. The comb<strong>in</strong>ation of ketam<strong>in</strong>e0.5 mgÆkg )1 IV <strong>and</strong> topical bupivaca<strong>in</strong>e <strong>in</strong>filtrationresulted <strong>in</strong> m<strong>in</strong>or reductions <strong>in</strong> pa<strong>in</strong> scoresª 2012 Blackwell Publish<strong>in</strong>g Ltd, Pediatric Anesthesia, 22 (Suppl. 1), 1–79 35
- Page 1 and 2: PediatricAnesthesiaVolume 22 Supple
- Page 3 and 4: doi: 10.1111/j.1460-9592.2012.3838.
- Page 5 and 6: 1.6 Contact informationCorresponden
- Page 7 and 8: RecommendationsChildren’s self-re
- Page 9 and 10: Topical anesthetic preparations, fo
- Page 11 and 12: 2.7.6 Laparoscopic surgeryGood prac
- Page 13 and 14: In order to assess pain, effective
- Page 16 and 17: Postoperative painl NCCPC-PV (Non-C
- Page 18 and 19: 68 Broome ME, Richtsmeier A, Maikle
- Page 20 and 21: however, reductions in the response
- Page 22 and 23: increased success rate (i.e., less
- Page 24 and 25: Newer preparations such as liposoma
- Page 26 and 27: Good practice pointLubricant contai
- Page 28 and 29: most effective. There are a number
- Page 30 and 31: 12 Bellieni C, Bagnoli F, Perrone S
- Page 32 and 33: venipuncture pain in a pediatric em
- Page 34 and 35: 172 van Twillert B, Bremer M, Faber
- Page 38 and 39: when compared with LA alone and sal
- Page 40 and 41: Peribulbar block improves early ana
- Page 42 and 43: Analgesia Table 5.5.1 Sub-umbilical
- Page 44 and 45: was more effective with less motor
- Page 46 and 47: with using landmark techniques (205
- Page 48 and 49: Good practice pointWound infiltrati
- Page 50 and 51: Analgesia Table 5.6.4 Urological Su
- Page 52 and 53: (298). Ketorolac did not influence
- Page 54 and 55: well as the epidural technique for
- Page 56 and 57: Good practice pointA multi-modal an
- Page 58 and 59: 14 Grainger J, Saravanappa N. Local
- Page 60 and 61: day-stay unit. Int J Paediatr Dent
- Page 62 and 63: tinuous epidural infusion in childr
- Page 64 and 65: 245 Morton NS, O’Brien K. Analges
- Page 66 and 67: 321 Taenzer AH, Clark C, Taenzer AH
- Page 68 and 69: Section 6.0AnalgesiaContents6.1 Ana
- Page 70 and 71: enhance systemic absorption. Lidoca
- Page 73 and 74: undergoes hepatic biotransformation
- Page 75 and 76: tein binding are reduced and the ha
- Page 77 and 78: a low-dose infusion but the child m
- Page 79 and 80: Table 6.6.1 Paracetamol dosing guid
- Page 81: steps that health care professional